Study S000302

A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase II Study to Evaluate the Efficacy and Safety of HRS9531 Injection in Obese Subjects With Obstructive Sleep Apnea (OSA)

ClinicalTrials.gov record

Registration

Registration: NCT06565871
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: QUADRUPLE
Status: UNKNOWN
Enrollment: 108
Start: 2024-08
Primary completion: 2025-12
Lead sponsor: Fujian Shengdi Pharmaceutical Co., Ltd.
Conditions: Weight Management
Interventions: DRUG:HRS9531 Injection; DRUG:Placebo Injection
Results posted: FALSE
Individual participant data sharing: UNDECIDED

Registered primary outcomes

Percentage change from baseline in body weight [Baseline,32week]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.